Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -1.75
- Piotroski Score 1.00
- Grade N/A
- Symbol (WENA)
- Company Anew Medical, Inc.
- Price $0.73
- Changes Percentage (-3.84%)
- Change -$0.03
- Day Low $0.73
- Day High $0.78
- Year High $5.11
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) N/A
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.06
- Trailing P/E Ratio -12.1
- Forward P/E Ratio -12.1
- P/E Growth -12.1
- Net Income $1.35 M
Income Statement
Quarterly
Annual
Latest News of WENA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Georgia investigators seek public's help in solving former model Kay Wenal's cold case murder
Kay Wenal, a striking and vivacious woman, was murdered in 2008, leaving a baffling case with little physical evidence....
By CBS News | 3 months ago
